Daniel Weinberger, PhD
Professor of Epidemiology (Microbial Diseases)Cards
About
Titles
Professor of Epidemiology (Microbial Diseases)
Co-director, Public Health Modeling Concentration; Affiliated Faculty, Yale Institute for Global Health
Biography
Dan Weinberger is a Professor in Epidemiology of Microbial Diseases at Yale School of Public Health. His research uses a combination of quantitative analysis, laboratory experiments and field work to understand the epidemiology and biology of respiratory infections. Recent work has focused on developing novel analytical methods for the evaluation of vaccines using time series and spatial data. He collaborates widely with public health agencies and academic organizations around the world on these issues. He earned his PhD in biological sciences from Harvard School of Public Health, with a focus on Infectious Disease Epidemiology, and completed a postdoctoral fellowship in the Division of International Epidemiology and Population Studies in the Fogarty International Center at the NIH.
Research: Our research is at the intersection of microbiology and epidemiology. We focus on understanding the biological and epidemiological drivers of respiratory infections, including pneumococcus, RSV, and influenza. Major research areas include understanding the biological drivers of the emergence of rare pneumococcal serotypes following vaccine introduction, developing novel statistical approaches to evaluate vaccine impact and effectiveness from observational data, and evaluating the importance of interactions among respiratory pathogens. We employ a variety of tools including experimental and quantitative approaches. Our work is funded by grants from the NIH/NIAID, the Bill and Melinda Gates Foundation, and the Emerging Infections Program (a collaboration between the CDC, the Connecticut Department of Public Health, and Yale), and our work has been supported by a number of industry partners. You can learn more about our research here.
Tool Development: I am the co-leader of PopHIVE.org, an innovative data platform that brings together diverse population health datasets from traditional surveillance sources, as well as healthcare data from Epic, Google Trends data, and more. With Stephanie Perniciaro, I developed and maintains a database of clinical trial data on pneumococcal vaccines (https://wisspar.com/). And with Jim Knight and Anna York, we developed Serocall, a software tool for quantifying the distribution of pneumococcal serotypes using whole genome sequence data.
Teaching: I teach the Public Health Surveillance course at YSPH. This class uses a mix of lectures, cases studies, and hands on data analysis exercises. Students learn to perform common surveillance analyses including aberration detection (e.g., CUSUM), time series analysis, and spatial cluster detection (SATSCAN). Students learn to do these analyses in R.
Appointments
Epidemiology of Microbial Diseases
ProfessorPrimary
Other Departments & Organizations
- Climate Change and Health
- CPIRT - Center for Pulmonary Injury, Inflammation, Repair and Therapeutics
- Epidemiology of Microbial Diseases
- Public Health Data Science and Data Equity
- Public Health Modeling
- Weinberger Lab
- Yale Institute for Global Health
- Yale School of Public Health
- Yale-UPR Integrated HIV Basic and Clinical Sciences Initiative
- YSPH Global Health Concentration
Education & Training
- Post-doctoral fellow
- Fogarty International Center, National Institutes of Health (2012)
- Postdoctoral Fellow
- Harvard School of Public Health (2010)
- PhD
- Harvard University (2009)
Research
Overview
I focus on identifying policy-relevant strategies to reduce the burden of vaccine-preventable respiratory diseases by using a unique combination of cutting-edge quantitative analysis, experimental tools, and community-based sampling. I use this unique combination of tools to understand the impact of existing interventions and to guide the development of more effective approaches. My work has received international exposure at meetings of the WHO and PAHO, and I have provided technical consultations based on my work to the CDC, WHO, GAVI The Vaccine Alliance, and numerous vaccine manufacturers (Pfizer, Merck, GSK, Affinivax, Matrivax). The lab has been supported by a diverse grant portfolio that includes funding from the NIH, the Bill and Melinda Gates Foundation, Pfizer, Merck, the Department of Veterans Affairs, and the Connecticut Emerging Infection Program. My work has focused largely on understanding the impacts of vaccines (against pneumococcus HPV, RSV), on developing improved vaccination strategies for children and adults, and on developing novel quantitative methods to evaluate the impact of public health interventions. This research employs a variety of methods including statistical and dynamic modeling, experimental microbiology, and bioinformatics. More recently, we have started performing field studies to understand the transmission dynamics of respiratory pathogens among adults in the US.
Medical Research Interests
Public Health Interests
Academic Achievements & Community Involvement
News & Links
News
- December 09, 2025
Yale School of Public Health’s PopHIVE project will expand health data access thanks to major grant
- November 11, 2025Source: MedPage Today
YSPH team seeks to democratize data with PopHIVE
- August 07, 2025Source: HuffPost
This severe bacterial lung infection is tearing through NYC — Here's what to know
- July 21, 2025
New YSPH Pilot Grants Support Innovative Interdisciplinary Research
Get In Touch
Contacts
Events
Everyone Daniel Weinberger, PhD